Enwave corporation

Beleggen in aandelen beurs China Shanghai Composite, Toronto, etc.
Plaats reactie
marcator
Forum actieveling
Forum actieveling
Berichten: 294
Lid geworden op: 17 Okt 2014 16:37
waarderingen: 223
Contact:

Re: Enwave corporation

Berichtdoor marcator » 29 Aug 2018 14:59

Er komen al enkele analyst reacties binnen nav de 3Q Enwave resultaten :

Cormark securities : koersdoel verhoogd van 1.6 naar 1.75 CAD
IA Securities : koersdoel verhoogd van 1.6 naar 1.70 CAD



ancaoli
Forum actieveling
Forum actieveling
Berichten: 461
Lid geworden op: 28 Jan 2018 18:54
waarderingen: 198
Contact:

Re: Enwave corporation

Berichtdoor ancaoli » 12 Sep 2018 19:19

Tussen alle biotech buzz toch een leuk berichtje betreffende Enwave;
EnWave Announces Shipment of a Pharmaceutical Radiant Energy Vacuum Freeze-Dryer for Merck
GlobeNewswireSeptember 12, 2018, 3:00 PM GMT+2
VANCOUVER, B.C., Sept. 12, 2018 (GLOBE NEWSWIRE) -- EnWave Corporation (ENW.V) (E4U.F) (“EnWave”, or the "Company") announced today that it has successfully completed Factory Acceptance Testing and has shipped its first 9 kW cGMP Radiant Energy Vacuum ("REV™") pharmaceutical freeze-dryer designed for Merck, known as MSD outside the United States and Canada. The pharmaceutical REV™ machine is designed to meet cGMP standards and to rapidly freeze-dry vials containing pharmaceutical products.

Successful completion of Factory Acceptance Testing demonstrates that REV™ freeze-drying technology met certain throughput and capacity specifications, designated by Merck.

The successful completion of the Factory Acceptance Testing with Merck marks a significant milestone in the scaled-up commercialization of EnWave’s proprietary REVTM technology in the pharmaceutical sector. Following installation, the equipment will undergo site acceptance testing prior to potential processing of pharmaceutical products using the technology.


Continuous processing of discrete dosage units of pharmaceutical products is sought by the pharmaceutical industry as it seeks more flexible and adaptable manufacturing processes. REV™ freeze drying provides a potential continuous drying platform to rapidly dry vaccines, monoclonal antibodies, therapeutic proteins, probiotics, enzymes, and small molecule therapeutics.
Vaste Portefeuille:Gala, Exmar, WRN, Accentis, Iep, Global G, SocGen, Roularta, Celyad, Biocartis, Zenitel, Geron, Argenx, Synergy, Enwave, Agfa, Accsys